LIVERMORE, Calf. — Two researchers at Sandia National Laboratories are using genetic resequencing tools to find a way to stop the COVID-19 pandemic in its tracks. Biochemist Joe Schoeniger and virologist Oscar Negrete are working on genetically engineering a deployable antiviral countermeasure for COVID-19 using CRISPR-based technology. “The goal is to find new ‘reloadable’ countermeasures […]
Tag Archives: CRISPR
Cutting it short
August 22, 2018 – 5:00 am
LIVERMORE, Calif. — Gene editing technology could one day eliminate diseases currently considered incurable. Thanks to a new test developed by Sandia National Laboratories scientists, that day is closer to dawning. The protein responsible for cutting out disease-causing bits of DNA is not safe to leave in the body for long. That’s why scientists are […]
Infectious diseases: CTRL + ALT + Delete
November 21, 2017 – 5:00 am
Sandia joins gene editing safety project LIVERMORE, Calif.— Gene editing is revolutionizing the bioscience research landscape and holds great promise for “deleting” diseases from human bodies. Sandia National Laboratories is working to make this technology safer and to ensure that one day it can be delivered into humans without triggering adverse immune system reactions or […]
Sandia, UCLA develop screening libraries to discover drug targets for viral infections
April 4, 2016 – 11:15 am
Project based on CRISPR genome-editing technology LIVERMORE, Calif. — As headlines highlight the threat of viruses like Ebola and Zika, researchers at Sandia National Laboratories and the University of California Los Angeles (UCLA) have teamed up to discover and uncover the viral mechanisms of infection by creating screening libraries based on CRISPR (clustered regularly interspaced […]